Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech ...

With the modality now in early clinical trials, experts say more efficiency, broader editing capabilities and delivery ...

About 60% of all cancer patients in the United States receive radiation therapy as part of their treatment. However, this ...

RNA splicing is a cellular process that is critical for gene expression. After genes are copied from DNA into messenger RNA, ...

Famed chip maker and hardware giant Nvidia has been investing significant resources into the healthcare and life sciences ...

Maravai LifeSciences Inc., a provider of life science reagents and services to researchers and biotech innovators, has ...

When it comes to surviving radiation, tardigrades really know their stuff, shrugging off doses that would annihilate most other life forms.

India's CRDMO sector, projected to hit $22-25 billion by 2035, is rapidly expanding due to cost advantages and quick startup ...

In an international collaboration, researchers have made an important breakthrough in the therapeutic delivery of microRNAs ...

California-based nonprofit Arc Institute and Stanford University, in collaboration with NVIDIA, unveiled Evo 2 on Wednesday ...

CRISPR technology, driven by Cas9, redefines gene editing, facilitating targeted DNA modifications that advance genetic ...